Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

about

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

Item

http://www.wikidata.org/entity/Q53897263

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

@en

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

@nl

type

Item

label

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

@en

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

@nl

prefLabel

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

@en

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

@nl

P1476

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

@en

P2093

Bramanti S

http://www.w3.org/2001/XMLSchema#string

Magagnoli M

http://www.w3.org/2001/XMLSchema#string

Masci G

http://www.w3.org/2001/XMLSchema#string

Santoro A

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.

High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.

Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.

Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.

High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report.

High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.

P2888

sj.bmt.1704527

P304

1261-1262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1704527

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lorenza Rimassa

Luca Castagna

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8597008

http://www.w3.org/2001/XMLSchema#string

P698

15107813

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer